Septic shock
Medically Reviewed by Dr. M. Salar Raza | Official SCFHS 2026 Blueprint
Clinical Pathway
Septic shock is a life-threatening condition characterized by circulatory, cellular, and metabolic abnormalities that are profound enough to substantially increase mortality, stemming from a dysregulated host response to infection. It is a subset of sepsis where patients require vasopressors to maintain an adequate mean arterial pressure and have elevated serum lactate despite adequate fluid resuscitation. Immediate management involves rapid administration of broad-spectrum antibiotics, aggressive intravenous fluid resuscitation (typically crystalloids), and vasopressors (e.g., norepinephrine) to restore and maintain adequate blood pressure and organ perfusion. Source control of infection (e.g., drainage of abscess, removal of infected device) is critical. Supportive care, including mechanical ventilation, renal replacement therapy, and glycemic control, is often required. Patients present with signs of severe infection and profound circulatory dysfunction, including persistent hypotension requiring vasopressors to maintain a mean arterial pressure of 65 mmHg or greater, despite adequate fluid resuscitation, and a serum lactate level > 2 mmol/L. Other manifestations of organ dysfunction may include altered mental status, oliguria, tachycardia, tachypnea, fever or hypothermia, and mottled skin.
Clinical Reasoning
Infection triggers an uncontrolled systemic inflammatory and anti-inflammatory response, leading to widespread endothelial dysfunction, increased vascular permeability, and microvascular thrombosis. This results in severe vasodilation and impaired oxygen utilization at the cellular level, causing global tissue hypoperfusion and profound hypotension that is refractory to fluid resuscitation, ultimately leading to multi-organ dysfunction and shock. Mitochondria are also affected, hindering cellular energy production. Septic shock carries a high mortality rate, ranging from 30-50% depending on the underlying cause, patient comorbidities, and timeliness of intervention. Survivors often experience long-term physical, cognitive, and psychological impairments as part of Post-Intensive Care Syndrome (PICS). Extremes of age (very young or very old),Immunosuppression (e.g., HIV, chemotherapy, corticosteroids),Chronic comorbidities (e.g., diabetes, chronic kidney disease, cancer, cirrhosis),Invasive medical devices (e.g., central lines, urinary catheters, ventilators),Recent surgery or trauma,Prior antibiotic use (contributing to resistant pathogens)
Sample MCQ
A 65-year-old patient is intubated in the Intensive Care Unit for severe septic shock. Despite aggressive fluid resuscitation, titrating vasopressors to mean arterial pressure targets, and ensuring an adequate cardiac index, the clinical team remains concerned about ongoing tissue hypoxia and impaired oxygen extraction due to microcirculatory dysfunction. Which of the following will best indicate adequate systemic perfusion?
- ACardiac index
- BCentral venous pressure
- CMixed venous oxygen saturation
- DPulmonary capillary wedge pressure
Correct Answer: Mixed venous oxygen saturation
### TLDR In severe septic shock with suspected microcirculatory dysfunction, **Mixed venous oxygen saturation (SvO2)** provides the best global assessment of the balance between oxygen delivery and consumption, thereby indicating adequate systemic perfusion. Other hemodynamic parameters primarily reflect oxygen delivery or fluid status, not the efficacy of oxygen extraction at the tissue level. ### Comparison Table | Option | Mechanism | Clinical Nuance | Key Distinction | |---|---|---|---| | Cardiac index | Cardiac output per body surface area; reflects oxygen delivery. | Can be normal/high in sepsis despite cellular hypoxia. | Does not indicate tissue oxygen extraction or utilization. | | Central venous pressure | Right atrial pressure; reflects right ventricular preload. | Primarily guides fluid resuscitation, not perfusion adequacy. | Poor indicator of global or regional tissue oxygenation. | | **Mixed venous oxygen saturation** | Oxygen content in pulmonary artery blood after tissue extraction. | Reflects balance of oxygen delivery and tissue consumption. | Best global indicator of effective tissue oxygenation. | | Pulmonary capillary wedge pressure | Left atrial pressure; reflects left ventricular preload. | Guides fluid therapy and left heart function, not perfusion. | Does not assess cellular oxygen extraction or utilization. | ### Detailed Breakdown The question describes a patient in severe septic shock where conventional parameters of macrohemodynamics (fluid resuscitation, vasopressors, cardiac index) have been optimized, yet concern for ongoing tissue hypoxia persists due to microcirculatory dysfunction. In this scenario, evaluating systemic perfusion requires a parameter that reflects the adequacy of oxygen extraction and utilization by the tissues. **Mixed venous oxygen saturation (SvO2)** is the most appropriate indicator for this purpose. SvO2 measures the oxygen content of blood in the pulmonary artery, representing the venous return from all systemic tissues. It is a critical indicator of the global balance between oxygen delivery (DO2) and oxygen consumption (VO2). A low SvO2 suggests inadequate oxygen delivery relative to demand, meaning tissues are extracting more oxygen, often indicating impaired perfusion or increased metabolic demand. Conversely, a normal or high SvO2 in a patient with adequate DO2 generally suggests that oxygen supply is meeting demand, implying adequate tissue perfusion. In septic shock, despite adequate DO2, microcirculatory dysfunction can impair oxygen extraction at the cellular level. Monitoring SvO2 directly assesses the net result of oxygen delivery and tissue extraction, providing insight into the efficacy of perfusion beyond just blood flow. * **Cardiac index** measures cardiac output normalized to body surface area, reflecting global oxygen *delivery* (DO2). While crucial, a normal or even high cardiac index in sepsis does not guarantee adequate tissue oxygenation due to maldistribution of blood flow and microcirculatory shunting, which can lead to areas of hypoxia despite overall high flow. * **Central venous pressure (CVP)** and **Pulmonary capillary wedge pressure (PCWP)** are measures of cardiac preload. They are primarily used to guide fluid resuscitation and assess cardiac filling pressures and function. They do not directly reflect tissue-level oxygenation or the balance between oxygen supply and demand. Optimal CVP or PCWP can be achieved without resolving cellular hypoxia, especially in the presence of microcirculatory dysfunction. Therefore, while cardiac index, CVP, and PCWP are vital for managing hemodynamics in septic shock, **Mixed venous oxygen saturation** uniquely provides a global assessment of the effectiveness of systemic perfusion at the tissue level by reflecting the oxygen extraction ratio.
Related Clinical Topics
AIDS
AIDS (Acquired Immunodeficiency Syndrome) is the final, most severe stage of HIV infection, characterized by a profoundly compromised immune system that makes individuals highly susceptible to opportunistic infections and certain cancers. It is diagnosed when the CD4+ T-cell count drops below 200 cells/mm³ or when specific AIDS-defining opportunistic illnesses develop. The cornerstone of AIDS treatment is highly active antiretroviral therapy (HAART), a combination of drugs that suppress HIV replication, preserve immune function, and prevent further progression. HAART significantly reduces viral load, increases CD4+ T-cell counts, and improves overall health. Treatment also includes prophylactic antibiotics to prevent opportunistic infections and specific therapies for any active infections or cancers. Symptoms of AIDS are primarily due to the opportunistic infections and cancers that take advantage of the severely weakened immune system. Common manifestations include persistent fever, chronic diarrhea, significant unintentional weight loss, night sweats, fatigue, swollen lymph nodes, and recurrent severe infections like Pneumocystis pneumonia, Kaposi's sarcoma, and toxoplasmosis. Neurological complications such as AIDS dementia complex can also occur.
Bradycardia
Bradycardia is a medical condition characterized by a slower than normal heart rate, typically defined as fewer than 60 beats per minute (bpm) in adults. While sometimes physiological and benign, it can also indicate underlying cardiovascular or systemic issues that impair the heart's ability to effectively pump blood. Treatment for bradycardia depends on its underlying cause, severity, and the presence of symptoms. Asymptomatic bradycardia, especially in athletes, often requires no intervention. Symptomatic bradycardia may necessitate discontinuing or adjusting causative medications, treating underlying conditions, or in severe cases, implanting a permanent pacemaker to regulate heart rhythm. Acute, unstable bradycardia may require intravenous atropine or temporary pacing. Clinical manifestations range from asymptomatic presentation to severe symptoms depending on the degree of bradycardia and the patient's cardiovascular reserve. Common symptoms include fatigue, dizziness, lightheadedness, syncope (fainting), shortness of breath, and chest pain. In critical cases, it can lead to confusion, hypotension, and signs of organ hypoperfusion.
Chronic Hepatitis C Virus infection
Chronic Hepatitis C Virus (HCV) infection is a persistent inflammatory condition of the liver caused by the hepatitis C virus, defined by the presence of detectable HCV RNA for at least six months. This long-term infection can progressively lead to significant liver damage, including fibrosis, cirrhosis, and hepatocellular carcinoma. Current treatment primarily involves direct-acting antiviral (DAA) medications, which are highly effective oral regimens targeting specific viral proteins to inhibit HCV replication. These therapies typically achieve a sustained virologic response (SVR) in over 95% of patients, effectively curing the infection. Treatment duration usually ranges from 8 to 12 weeks, depending on the specific regimen and patient factors. Chronic HCV infection is often asymptomatic for many years, leading to a silent progression of liver disease. When symptoms do appear, they are often non-specific, such as fatigue, malaise, nausea, and right upper quadrant discomfort. As the disease advances to cirrhosis, signs of liver decompensation may emerge, including jaundice, ascites, peripheral edema, spider angiomata, and hepatic encephalopathy.
SMLE Preparation Resources
Master the 2026 SMLE
Explore more clinical protocols in the SMLEREVISE Clinical Knowledge Library.
Try the QBank & Scaled Mocks